DNTH312 is an internally developed bifunctional fusion protein targeting potent inhibition of active C1s (aC1s) and BAFF/APRIL, two validated pathways with complementary disease modifying mechanisms ...

In patients with Guillain-Barré syndrome, tanruprubart yielded significant improvements in muscle strength, with patients ...

Omeros Corporation (Nasdaq: OMER) today announced that the Centers for Medicare & Medicaid Services (CMS) has granted New Technology Add-On Payment (NTAP) status for YARTEMLEA ® (narsoplimab-wuug) ...

The complement system represents an important immune defence mechanism utilising membrane attack complexes (MAC) as effectors. Here the authors show that the C9 component of MACs forms non-cytolytic ...

Researchers published findings on June 3, 2026, describing an oral pill that burns fat by targeting skeletal muscle and brown adipose tissue through a redesigned beta-2 adrenergic receptor pathway, ...

Disclosure: Conran has received grants from the Sao Paulo Research Foundation and Novartis AG; and participated in data safety monitoring or advisory boards for Novo Nordisk. Rees has participated on ...

The early period of life is a critical phase in which the immune system must learn to tolerate harmless environmental stimuli ...

Controlling how oxygen reacts is important for improving technologies such as batteries, fuel cells and environmentally ...

This Research Topic is the second volume of the series on the "Role of genotoxic stressors and survival / metabolic pathways in inflammatory activation and ...

A new study shows that senescent cells increase acetyl-CoA production which enables epigenetic modifications that boost ...

The study presents valuable findings on early behavioral phenotypes that arise in an ADHD-associated adgrl3.1 mutant zebrafish, using a new behavioral approach w ...